30 results about "Glandular secretion" patented technology

A semi-solid screen like wafer comprised of odor elimination and neutralization chemicals or comprised of animal urine, glands and gland secretion or comprised of natural plant scents or comprised of any combination thereof in a freeze dried state or suspended state in a gelatin material rehydratable or dissolvable in human urine designed to cover, eliminate and neutralize human urine scent in the wilderness environment and to lure and attract wildlife into the specific wilderness area.

An animal scent composition includes a liquid animal scent component and a carrier composition. The scent component can include animal urine, other animal glandular secretions and/or gland materials. The carrier composition can include sodium bicarbonate, calcium carbonate, magnesium carbonate, baking powder and/or cornstarch, along with silicon dioxide. The resulting mixture is dried. The dried mixture is fed into a milling device and broken into small pieces and fine powder. The resulting small pieces and fine powder are fed into a sifter, where the milled dry mixture is sifted and possibly further processed to collect a fine powdered animal scent composition. The resulting fine powdered animal scent composition is then placed into flexible bottles and capped with a cap, such that compression of the flexible bottle causes a fine aerosol or suspension of the fine powdered animal scent composition to be ejected from the flexible bottle into the surrounding atmosphere.

The invention relates to an aweto medicated wine and process for preparation, which belongs to the nourishing and health preserving field. The invention comprises aweto, poria cocos, Chinese yam, eucommia ulmoides, alpinia oxyphylla, wolfberry fruit, radix adenophorea, cuscuta chinensis, liriope, tortoises shell, sucrose and sorghum wine whose alcohol is 42-54 degrees (v/v). In the process of preparation, the herbal medicines are immersed in the wine, and sealed to store for 30-50 days at normal temperature, then solid and liquid-state admixture is separated, and the supernatant which is obtained is a desired product. The invention has no toxin and side effect, and has the functions of moistening lung to stop coughing, nourishing liver and kidney, replenishing essence to improve vision, strengthening essence to invigorate vital energy, nourishing yin and promoting glandular secretion, nourishing spleen and strengthening stomach, anchoring mind and diuretic, lowering blood pressure and decreasing blood glucose, reinforcing blood circulation and the like. The invention can be used not only for health care but also for treatment.

The invention discloses a new process for preparing a traditional Chinese medicine belladonna liquid extract. The belladonna liquid extract is a domestic widely-used plant intermediate and clinically mainly used for gastric acid duodenal ulcer, angina of gastrointestinal tract, kidney and gallbladder and the like and has functions of removing smooth muscle spasm, restraining glandular secretion and the like. Original medicinal materials of the belladonna liquid extract are belladonna herb, and the belladonna herb is whole herb of Atropa belladonna L. A current main preparation method of the belladonna liquid extract is a percolation method, and the percolation method is long in consuming time, more in solvent consumption and insufficient in effective component enrichment. The invention discloses a process for preparing the belladonna liquid extract by ultrasonic dynamic multi-stage countercurrent extraction based on the conditions. According to the process, effective plant components are sufficiently extracted by the aid of ultrasonic cavitation effect, the dynamic multi-stage countercurrent extraction saves energy, and organic solvents are circularly used, so that the belladonna liquid extract is rapidly and effectively prepared. According to the process, an ultrasonic method is used in a dynamic multi-stage countercurrent extraction system for the first time.

The invention discloses dsRNA (double-stranded Ribose Nucleic Acid) for inhibiting expression of a salivary glandular secretion polypeptide gene of wheat aphids and application thereof. The invention provides a dsRNA molecule which is as shown in a sequence 2 in a sequence table. The invention also protects a DNA (Deoxyribose Nucleic Acid) molecule for encoding the RNA molecule. The invention also protects application of the RNA molecule or the DNA molecule. The application comprises at least one of the following application: (1) preventing and treating aphids; (2) promoting death of the aphids; (3) inhibiting the aphids from growing; (4) inhibiting expression of the in-vivo salivary glandular secretion polypeptide gene of the aphids. The dsRNA and the application thereof have important application value for preventing and treating the aphids in the agricultural production.

The invention discloses a compound Ofloxacin solution and a preparation method thereof, aiming at providing a solution with the advantages of treating digestive tract infections and respiratory tract infections of birds with rapid effect, treating both principal and secondary aspects of diseases and reducing drug-applied times and a preparation method thereof. The solution can be injected or orally taken and proper treating methods and administration approaches can be adopted according to disease states and the specific conditions of culturists. Every 100L of solutions comprises 1-10 kg of Ofloxacin, 3-15 kg of lincomycin hydrochloride, 0.05-0.5 kg of atropine sulfates, 0.2-2 kg of doxofylline, 0.01 kg of EDTA (Ethylene Diamine Tetraacetic Acid)-2Na, 10 kg of dimethylacetylamide and 0.5 L of hydrochloric acid. Because the Ofloxacin and the lincomycin hydrochloride are adopted as antibacterial components, the compound Ofloxacin solution can effectively solve the problems of bacterial drug resistance and takes effect on common bacteria causing the digestive tract infections and the respiratory tract infections; and meanwhile, the doxofylline can effectively relieve cough and asthma and inhibit respiratory symptoms, and the atropine sulfates have the rapid effects of inhibiting glandular secretion and reducing the liquid contents of digestive tracts and the respiratory tracts.

The invention discloses bitter gourd herbal tea and a preparation method of the bitter gourd herbal tea. The bitter gourd herbal tea is prepared from the following raw materials in parts by weight: 70-80 parts of bitter gourd pieces, 20-30 parts of florists chrysanthemum flowers, 20-30 parts of scaphium scaphigerum, 20-30 parts of honeysuckle, 20-30 parts of lophatherum gracile, 20-30 parts of lemon, 20-30 parts of mint leaves, 10-20 parts of liquorice, 13-16 parts of olive oil, 12-15 parts of mullet meat, 7-8 parts of fragrant-flowered garlic juice, 4-5 parts of club fungi, 5-6 parts of gluten, 5-7 parts of wick cakes, 4-6 parts of dry hawthorn fruits, 8-10 parts of malabar spinach, 9-11 parts of citrus, 7-9 parts of kiwi fruits, 1-2 parts of perilla leaves, 1-2 parts of broad bean flowers, 1-2 parts of radix ophiopogonis, 1-2 parts of cervus elaphus Linnaeus, 1-2 parts of peony flowers, a proper amount of water and 15-20 parts of nutritional additives. According to the invention, bitter gourd is taken as the main material, and the bitter gourd herbal tea has the efficacies of reinforcing blood capillary, promoting blood circulation, preventing arteriosclerosis, eliminating summer-heat by cooling, diminishing swelling and detoxifying, decreasing blood sugar and blood fat, and resisting inflammatory, and the added traditional Chinese medicines have the efficacies of nourishing the Yin, promoting glandular secretion, moistening lung and clearing away the heart-fire.

The invention provides a compound enteritis capsule. It is characterized by simple treatment, convenient usage and functions of treating bacillary dysentery, acute and chronic enteritis. It makes use of the anti-biotic effect for bacillus coli and Bacillus dysenteriae of furazolidone, acts on intestine smooth muscle by using chlorhydric acid diphenoxylate, gets rid of crawl reflection of partial mucosa to reduce crawl by inhibiting intestine mucosa receptor, and increases intestine wall stage contraction and promotes water back-absorption in the intestine. The atropine sulfate can relieve intestine smooth muscle spasm and inhibit glandular secretion. The capsule comprises five chemical medicine, it can shorten the treating period for bacillary dysentery and acute enteritis, increase cure rate for various chronic colitis, and reduce pain for patient during injection, intravenous drip, bowel lavage and taking traditional medicine.

The invention discloses a composition for treating chicken necrotizing enterocolitis and a preparation method thereof and aims to provide a composition for treating chicken necrotizing enterocolitis infection with rapid desired effect, bacterium drug-resistant reduction and both principal and secondary treatment of diseases and a preparation method thereof. The composition for treating chicken necrotizing enterocolitis is prepared by the following raw materials in percentage by weight: 2-10 apramycin sulfate, 2-15 sodium orosulfan, 0.4-3 trimethoprim lactate, 0.1-0.5 atropine sulfate and the balance of tannic acid. The composition adopts two phytopathogenic components, i.e. the apramycin sulfate and the sodium orosulfan, wherein the apramycin sulfate taken orally is difficult to absorb andgenerates contact sterilization, the sodium orosulfan taken orally takes effect by humoral secretion, and pathogens are killed in two ways. The antibacterial effects of the apramycin sulfate and thesodium orosulfan are enhanced by the trimethoprim lactate, the atropine sulfate reduces glandular secretion, and the tannic acid forms a protective film with protein to prevent bacteria from contacting the intestinal canal and effectively protect the intestinal mucosa.

The invention provides application of long-chain non-coding RNAGAS5 to preparation of a medicament for treating skeleton system diseases. A GAS5 adenovirus is applied to carry out treatment on osteoporosis, and the pharmacological action of the GAS5 adenovirus is similar with that of teriparatide, and both the GAS5 adenovirus and the teriparatide are medicaments for promoting bone formation. The difference is that the GAS5 is naturally expressed in various types of cells in vivo, has no specific glandular secretion and cannot cause corresponding inhibition from endocrine glands of the human body; and the GAS5 only promotes MSCs to be differentiated into bone cells in vivo, and has no obvious influence on osteoclast. Therefore, the long-chain non-coding RNAGAS5 is higher in osteoporosis resistance, and has no similar problem of small dosage range of the teriparatide. In addition, due to the unique action mode of the adenovirus, the GAS5 can take an acting effect of resisting to osteoporosis only by injecting in vitro for once, and acceptability and comfort of a patient can be greatly promoted.

The invention relates to a sexual life electronic therapy fun device which comprises a condom bonding type and a non-condom type. The device comprises an electrode pair, and at least one electrode enters a female vagina. Two electrodes of the electrode pair are connected to a positive electrode and a negative electrode of an electronic physiotherapy instrument through conductive wires. The electronic physiotherapy instrument has an intensity adjustment switch. The electrode pair of the condom bonding type electronic therapy fun device is fixed to a condom, or one electrode in the electrode pair is fixed to the condom, and the other electrode is attached to a female skin. The electrode pair of the non-condom type electronic therapy fun device directly sleeves a male penis in use, or one electrode in the electrode pair sleeves the penis, and the other electrode is attached to a female skin. The electrode pair is made of conductive and soft materials such as carbon fibers, conductive silica gel sheets and metal. According to the device, a current loop is formed in a female vaginal tissue by using the electrodes, micro-electric stimulation is generated, vaginal contraction is promoted,and glandular secretion is stimulated. The sex life electronic therapy fun device is non-toxic, harmless, safe and reliable and is convenient to use, the decline of a female organ can be delayed, andthe fun of sexual life is increased.

The invention relates to a composition for treating chicken ventriculitis and a preparation method of the composition. The composition is prepared from the following ingredients in parts by weight: 5-10 parts of penicillin, 5-10 parts of streptomycin, 10-30 parts of cortex fraxini, 10-30 parts of zinc oxide and 10-30 parts of rhizoma atractylodis macrocephalae; the composition has the funcitons ofrepairing gastric mucosa, eliminating nipple swelling and inhibiting glandular secretion, has very good prevention and treatment effects for various ventriculitis diseases, is convenient to use and relatively low in cost, has very good prevention and control effects on viral ventriculitis, fodder mycotoxin ventriculitis and ventriculitis of which the cause is unknown, and is a composition which is simple to use and low in price.

The present invention relates to an ophthalmic gel prepared for the first time as an active ingredient of a drug, atropine sulfate, which can selectively block M-cholinergic receptors and resist the M-receptors of acetylcholine and its cholinergic drugs. Body stimulant, can contact smooth muscle spasm, can simulate glandular secretion, dilate pupil. In the present invention, atropine sulfate is made into ophthalmic gel for the first time, which not only solves the problem that eye drops are easily diluted by tears and the residence time in the eye is short; moreover, it improves the bioavailability of the active ingredients of the medicine, increases the curative effect and the safety of medication. The main technical content is: atropine sulfate, hydroxypropyl methylcellulose, boric acid, borax, and chlorinated benzalkamine to make a stable water-soluble transparent cream body, which forms a layer of breathable mesh film on the eye surface after use. It has a long-lasting effect and is mainly used for fundus examination and dilation before optometry, mydriasis before eye surgery, and postoperative adhesion prevention. It can also be used for the treatment of keratitis, iridocyclitis, etc.

The invention discloses a medicinal composition for treating perimenopausal xerophthalmia. The medicinal composition has the innovative structure shown in the description. The medicine provided by the invention can obviously improve the dry eye SIT caused by decrease of the perimenopausal gonadal hormone concentrations, change the tear protein components, promote the eyelid glandular secretion, and effectively reduce the inflammatory cell infiltration of the androgen dysfunctional xerophthalmia and the basal cellular atrophy of the corneal epithelium, belongs to a medicine which is safe and effective, has the simple administration route, has small side effects, and can be used by patients for a long term in treating the dry eye disease, and therefore, the medicinal composition has the wide clinical application and promotion values.

A traditional Chinese medicine composition for treating anorectal diseases caused by spinal nerve disorder is characterized by being prepared from, by weight, 8-12 parts of radix scutellariae, 27-32 parts of radix paeoniae alba, 8-10 parts of fresh ginger, 8-12 parts of Chinese dates, 5-8 parts of radix glycyrrhizae preparata, 15-20 parts of pinellia rhizoma prepared by ginger, 28-32 parts of radix puerariae, 28-32 parts of radix clematidis, 28-32 parts of caulis lonicerae, 28-32 parts of herba siegesbeckiae, 28-32 parts of semen coicis, 28-32 parts of herba lycopodii, 10-14 parts of rhizoma curcumae longae, 8-12 parts of rhizoma cibotii, 18-22 parts of radix polygonum multiflorum preparata and 28-32 parts of caulis spatholobi. The traditional Chinese medicine composition has the effects of reinforcing the kidneys and smoothing Du meridian, soothing the liver and relieving depression, relaxing the muscles and tendons, promoting the circulation of qi, dredging the collaterals, nourishing the liver and kidneys, strengthening the spinal column, strengthening the muscles and bones, clearing the liver, nourishing liver blood, soothing the liver-gallbladder, resisting inflammation, easing pain, relieving smooth muscle spasm, inhibiting glandular secretion, inhibiting nerve root inflammation and improving immunity; a satisfactory effect is achieved for treating anorectal diseases caused by spinal nerve disorder.

The invention discloses an air bag for clinging to parotid gland surgery postoperative wound, and relates to the field of medical treatment and nursing. The air bag is characterized in that an air bagbody comprises a clinging layer, a latex layer and an air cushion layer, the air cushion layer is positioned on the outermost layer, the latex layer is positioned on an intermediate layer and clingsto the air cushion layer, the clinging layer is positioned on the innermost layer and clings to the latex layer, and the latex layer comprises, by weight, 80-85 parts of natural latex and 15-20 partsof nanometer silica gel; a plurality of protruded particles with the particle sizes of 0.1-0.5 mm are arranged on the surface of the clinging layer, and traditional Chinese medicine mixture extract isattached onto the clinging layer. The air bag has the advantages that the impact resistance, the fixing properties, the clinging properties, the air permeability and the comfort of the integral fixing air bag can be improved for the postoperative wound on the face of a patient, and certain pain relieving effects further can be realized by the air bag; pressurization effects further can be realized by the air bag, accordingly, glandular tissues can be suppressed, glandular secretion can be inhibited, and bleeding stopping and subcutaneous hematoma and postoperative salivary fistula reducing effects can be realized by the air bag.

Antracele is a common and frequently-occurring disease in the ear-noise-throat department, is caused by mucous gland blockage, retention of gland secretions, or inflammations or allergic reactions, and retention of a serous fluid which permeates out of blood capillaries in submucosa connective tissues, is formed by gradual expansion, mainly shows as headache and facial discomfort, and cause impaired vision sometimes. At present, antracele is mainly treated by operation in clinical, and operation pathways pass through aditus antrum, inferior meatus and a labiogingival groove; the operation pathways passing through the aditus antrum and the inferior meatus have the defects of poor visual field and high postoperative relapse rate; the conventionally maxillary sinus radical operation has the defects of large trauma and high postoperative response; although an endoscope is used in modern times, the operative treatment still has the defects of high mental stress of a patient, high cost, requirement of staying in hospital and the like. In the invention, a non-operation medicinal formula for treating antracele is mainly used for treating antracele. The medicinal formula is developed and prepared according to years of clinical experience, and has the advantages of reduction in the pain of patients, low cost, increase in the working efficiency, improvement on the life quality, easiness for operating, good curative effect and wide application prospect.